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Abstract: Traditionally, cardiac surgery has been performed through a median sternotomy, which allows the surgeon 
generous access to the heart and surrounding great vessels. As a paradigm shift in the size and location of incisions 
occurs in cardiac surgery, new methods have been developed to allow the surgeon the same amount of dexterity and 
accessibility to the heart in confined spaces and in a less invasive manner. Initially, long instruments without pivot 
points were used, however, more recent robotic telemanipulation systems have been applied that allow for improved 
dexterity, enabling the surgeon to perform cardiac surgery from a distance not previously possible. In this rapidly 
evolving field, we review the recent history and clinical results of using robotics in cardiac surgery. 
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1. Introduction 
 
Since the advent of laparoscopic cholecystectomy, 
various surgical disciplines have successfully adopted 
endoscopic technology, leading to decreased morbidity 
and shorter recovery times. Most of these operations 
have involved the removal of an organ rather than the 
delicate construction of a coronary bypass anastomosis 
or valve repair. This is likely due to the fact that long, 
nonarticulated instruments with fixed pivot points that 
are the cornerstone of endoscopic surgery significantly 
limited dexterity. Furthermore, the lack of depth 
perception with traditional video systems has also made 
delicate reconstructive surgery difficult. Therefore, 
cardiac surgery has been slow to adopt such endoscopic 
techniques. With the development of robotic surgical 
systems surgeons have begun to explore the possibility 
of altering current approaches to cardiovascular surgery. 
Cardiac surgery has usually been, and in most instances 
continues to be, performed via a median sternotomy. 
This incision allows direct and ample access to the heart 
and all of its surrounding structures. Thus, the surgeon is 
able to readily cannulate the structures necessary to 
initiate cardiopulmonary bypass (CPB). Furthermore, the 
exposure allows the surgeon to perform coronary artery 
bypass grafting (CABG), as well as intracardiac valve 
repair and replacement. 
Recently, there has been a shift in the way cardiac 
surgery is performed. An extensive effort is underway to 
develop and perform less invasive cardiac surgery 
through incisions other than the classic median 
sternotomy. This changing paradigm raises a number of 
issues. No longer can the surgeon readily access the 
thoracic cavity to place cannulae for CPB or perform 
surgical maneuvers manually. In fact, new techniques for 
remote cannulation have been developed (Pompili et al., 
1996; Stevens et al., 1996) Furthermore, with the 
changes in size and location of incisions, visualization 
systems and robotic telemanipulation systems have had 
to be developed to allow the surgeon to perform precise 
surgical maneuvers that mimic human dexterity. This 
article will review the history of robotic applications in 
cardiac surgery and highlight our early clinical 
experience. 
2. History of Robotic Systems 
 
Six degrees of freedom are required to allow free 
orientation in space. Thus, standard endoscopic 
instruments with only four degrees of freedom 
dramatically reduce dexterity. When working through a 
fixed entry point, such as a trocar, the operator must 
reverse hand motions (the fulcrum effect). At the same 
time, instrument shaft shear, or drag, induces the need 
for higher manipulation forces, leading to hand muscle 
fatigue. Also, human motor skills deteriorate with visual-
motor incompatibility, which is commonly associated 
with endoscopic surgery. Computer-enhanced 
instrumentation systems have been developed to 
overcome these and other limitations. These systems 
provide both telemanipulation and micromanipulation of 
tissues in confined spaces. The surgeon operates from a 
console, immersed in a three-dimensional view of the 
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operative field. Through a computer interface, the 
surgeon’s motions are reproduced in scaled proportion 
through “microwrist” instruments that are mounted on 
robotic arms inserted through the chest wall. These 
instruments emulate human X-Y-Z axis wrist activity 
throughout seven full degrees of freedom. 
During the early 1990s, extensive research conducted on 
robotic applications in surgery resulted in the emergence 
of two robotic systems. Based on technology developed 
by the Stanford Research Institute, Frederic Moll, MD, 
Robert Younge, and John Freund, MD developed the da 
Vinci System (Intuitive Surgical, Mountain View, CA) in 
1995. The system stressed the telepresence concept, with 
the surgeon immersed in a full three-dimensional 
experience that created the sense that the operative site 
was directly in view. The hand motions exactly 
replicated the motions of open surgery through the use of 
“endowrists.” As a result, the learning curve was 
minimized. The Computer Motion (Santa Barbara, CA) 
system, Zeus was developed as an integrated robotic 
surgical system. Yulun Wang, PhD, founded the 
company in 1989 and initially developed a voice-
controlled robotic arm called the Automated Endoscopic 
System for Optimal Positioning (AESOP), which would 
be used as a laparoscopic camera holder. The Zeus 
system did not attempt to create an immersive intuitive 
interface; rather, the surgeon was fully aware of 
performing a robotic procedure. The fulcrum effect of 
laparoscopic surgery was retained, as well as the obvious 
monitor for viewing. 
 
3. AESOP Robotic System 
 
In 1994, AESOP became the first medical robot to 
receive Food and Drug Administration (FDA) approval 
in the United States. Two years later, voice control by 
the surgeon was added, allowing for exact, hands-free 
control of an endoscope during an operation. This robotic 
arm is capable of responding to over 20 simple voice 
commands. In 1996, while general surgeons were already 
using this device, Carpentier performed the first video-
assisted mitral valve repair via a minithoracotomy using 
ventricular fibrillation (Carpentier et al., 1996). Three 
months later, our group at East Carolina University 
(ECU) completed a mitral valve replacement using a 
microincision, videoscopic vision, percutaneous 
transthoracic aortic clamp, and retrograde cardioplegia 
(Chitwood et al., 1997). In 1997, Mohr first used the 
AESOP voice-activated camera robot in minimally 
invasive videoscopic mitral valve surgery (Mohr et al., 
1998). Microincisions or port incisions (4 cm) were used 
and most of the operation was performed via secondary 
or assisted vision. In June 1998, our group performed the 
first completely video-directed mitral operation in the 
United States using AESOP and a Vista (Vista 
Cardiothoracic Systems, Inc., Westborough, MA) three-
dimensional camera (Chitwood et al., 1997). Continued 
experience, advances in three-dimensional videoscopy, 
and voice activated camera control with AESOP allowed 
the use of even smaller incisions with better visualization 
of both valvular and subvalvular components of the 
mitral valve. The voice-activated camera provides direct 
eye-brain-action translation for the surgeon without an 
intermediary assistant. Camera manipulation 
requirements are diminished, movements are more 
predictable, and lens cleaning is reduced, enabling the 
surgeon more operative flexibility and speed. 
 
4. Zeus Robotic System 
 
The Zeus system is composed of three interactive arms, 
mounted directly on the operating table compared with 
the da Vinci, which is positioned on the floor next to the 
patient (Figs. 1A and 1B). The surgeon’s movements are 
digitalized and filtered by a signal processor before being 
relayed to the robotic arms. The surgeon is seated at a 
remote console, and handles provide a sensitive robotic 
interface. The system mechanically relays the surgeon’s 
hand movements to a computer controller. The basic 
Zeus visualization system is two-dimensional; however, 
it can be used in combination with new and 
independently developed three-dimensional visualization 
systems. The surgeon remains seated with the 
endoscopic image displayed at eye level and close to the 
hands. Although the Zeus system lacks a fully articulated 
wrist and allows only four degrees of freedom, the 
instrument diameter is a small 3.9 mm compared with 
the 7 mm da Vinci arm. Recently, some instrument tips 
have been developed that provide five degrees of 
freedom through the use of a “microwrist.” More than 20 
different end-effectors exist within this system, including 
needle drivers, tissue graspers, and microscissors. These 
instruments are easily interchangeable during the 
surgical procedure. The arms on which these instruments 
are mounted are lightweight and flexible, allowing the 
surgical team to stand close to the patient. 
 
 
Fig. 1A. Zeus tableside robotic system. 
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Fig. 1B. da Vinci tableside robotic system. 
 
5. da Vinci Robotic System 
 
Three components comprise the da Vinci system: a 
surgeon console, an instrument cart, and a visioning 
platform. The operative console is physically remote 
from the patient and allows the surgeon to sit 
comfortably, resting the arms ergonomically with his or 
her head positioned in a three-dimensional vision array. 
Through sensors, the surgeon’s finger and wrist 
movements are digitally registered in computer memory 
banks; these actions are efficiently transferred to an 
instrument cart, which operates the synchronous end-
effector instruments (Fig. 2). Wrist-like instrument 
articulation precisely emulates the surgeon’s actions at 
the tissue level and enhances dexterity through combined 
tremor suppression and motion scaling. A clutching 
mechanism enables readjustment of hand positions to 
maintain an optimal ergonomic attitude with respect to 
the visual field. 
 
 
Fig. 2. End-effector arms of da Vinci system 
demonstrating multiple axis of rotation. 
 
This clutch acts very much like a computer mouse, 
which can be reoriented by lifting and repositioning it to 
re-establish unrestrained freedom of computer activation. 
The three-dimensional digital visioning system enables 
natural depth perception with high-power magnification 
(10X). Both 0° and 30° endoscopes can be manipulated 
to look either “up” or “down” within the heart. Access to 
and visualization of the internal thoracic artery, coronary 
arteries, and mitral apparatus is excellent. The operator 
becomes ensconced in the three-dimensional operative 
topography and can perform extremely precise surgical 
manipulations devoid of traditional distractions. 
Through 1 cm ports, instruments are positioned near the 
cardiac operative site in the thorax, and the camera is 
passed via a 4 cm working port used for suture and 
prosthesis passage (Fig. 3). Every analog finger 
movement, along with inherent human tremor at 8–10 
Hz/second, is converted to binary digital data, which are 
smoothed and filtered to increase micro instrument 
precision. The wrist-like articulation and motion 
suppression allow both increased precision and dexterity 
with the surgeon becoming truly ambidextrous. Six 
degrees of freedom are offered by this combination of 
trocar-positioned arms (insertion, pitch, and yaw) and 
articulated instrument wrists (roll, grip, pitch, and yaw). 
 
 
Fig. 3. 4-cm incision in the right 4th intercostal space. 
 
 
 
Fig. 4. View with the da Vinci system of the mitral 
valve. 
90 
Full X-Y-Z axis agility is affected by coordinating foot 
pedal clutching and hand motion sensors. Hand activity 
at the console is exactly reproduced at the surgical field 
while foot pedals control the camera position and focus. 
Coordination of these eye-hand-foot movements enables 
the surgeon to ratchet articulated wrists smoothly 
through every coordinate, allowing for complex 
instrument positions while providing maximum 
ergonomic comfort. Fig. 4 shows the surgeon’s operative 
field during a da Vinci mitral repair. 
 
6. Robotics in Cardiac Valve Surgery 
 
In 2001, Felger reported on 72 robotically directed mitral 
valve surgeries performed at ECU with the AESOP 
system. These patients were compared to 55 manually 
directed patients (an assistant directed by the surgeon) 
undergoing mitral valve surgery (Felger et al., 2001). 
Perioperative data analysis revealed that 75% of the 
robotically directed group underwent mitral valve repair, 
which included quadrangular resections, sliding plasties, 
chord replacement/repair, and Alfieri-plasties. Despite 
the complexity of these cases, robotically directed cross-
clamp times were significantly less than the manually 
directed cohort (90.0 ± 4.6 minutes versus 128.0 ± 4.5 
minutes; p<0.001). Cardiopulmonary bypass times were 
less in the robotically directed group (143.3 ± 4.6 
minutes versus 172.8 ± 5.7 minutes; p<0.001). This time 
difference reflects the importance of robotic assistance, 
as less time was required for positioning the endoscope 
and cleaning the lens, enabling the surgeon to perform 
the operation more expeditiously. Comparative lengths 
of hospital stay were the same for the robotically directed 
and manually directed groups, but significantly less than 
a historical control of conventional sternotomy mitral 
surgery patients (4.6 ± 0.3 days vs. 7.9 ± 0.6 days; 
p<0.001). There were two (3%) conversions to 
sternotomy secondary to bleeding in the robotically 
directed group. There were no permanent neurologic 
events in this group and no patients underwent prolonged 
ventilation (>48 hours). Thirty-day operative mortality 
was 2.3%, demonstrating both the efficacy and safety of 
this approach. 
Other groups have reported similar success using 
AESOP with minimally invasive mitral valve surgery. 
Mishra and colleagues from the Escorts Heart Institute in 
India reported their experience in 221 patients, in which 
the AESOP system was used in 120 patients (Mishra et 
al., 2002). Perfusion and aortic cross-clamp times were 
126 ± 41 minutes and 58 ± 16 minutes, respectively. 
When compared to a conventional incision cohort, there 
was no significant difference. Most of these operations 
(81%) involved valve replacement accounting for the 
shorter perfusion times when compared with our series 
where only 25% of mitral valve operations were 
replacements. Excellent clinical results were achieved 
with no permanent neurologic deficits and an operative 
mortality of 0.45%. There were no reoperations in a 
follow-up period of 16 months, again demonstrating the 
safety and efficacy of robotically assisted minimally 
invasive mitral valve surgery. 
In May 1998, using an early prototype of the da Vinci 
articulated “microwrist,” Carpentier performed the first 
true robotic mitral valve repair (Carpentier et al., 1998). 
In May 2000, our group performed the first complete 
repair of a mitral valve in North America using the da 
Vinci system (Chitwood et al., 2000). With articulated 
wrist instruments, a trapezoidal resection of a large P2 
scallop was performed with the defect closed using 
multiple interrupted sutures, followed by implantation of 
a #28 Cosgrove annuloplasty band. The same year we 
completed an FDA safety and efficacy clinical trial in 10 
patients. Quadrangular leaflet resections, leaflet sliding 
plasties, chord transfers, polytetrafluoroethylene chord 
replacements, reduction annuloplasties, and annuloplasty 
band insertions were all successfully performed. The 
mean total arrest time was 150 minutes, with 52 minutes 
used for leaflet repairs. Of the total arrest time, a mean of 
42 minutes was needed to place an average of 7.5 
annuloplasty band sutures. Total operating room time 
averaged 4.8 hours. There were no device-related 
complications, and only one re-exploration for bleeding 
from an atrial pacing wire. The average postoperative 
stay was 4 days (range 3-7 days). At three-month follow-
up, echocardiography revealed nothing more remarkable 
than trace mitral regurgitation. All patients returned to 
normal activity by one month after surgery (Chitwood 
WR Jr & LW., 2001). 
We recently published our results of the first 38 mitral 
repairs with the da Vinci system (Nifong et al., 2003). 
For data analysis and comparison, patients were divided 
into two cohorts of 19 patients (early experience and late 
experience). Total robotic time represents the exact time 
of robot deployment after valve exposure and continued 
until the end of annuloplasty band placement. This time 
decreased significantly from 1.9 ± 0.1 hours in the first 
group to 1.5 ± 0.1 hours in the second group (p=0.002). 
Concurrently, leaflet repair time fell significantly from 
1.0 ± 0.1 hours to 0.6 ± 0.1 hours, respectively 
(p=0.004). Also, total operating time decreased 
significantly from 5.1 ± 0.1 hours to 4.4 ± 0.1 hours in 
the second group of patients. Furthermore, both cross-
clamp and bypass times decreased significantly with 
experience. Similar time trends were reported in a later 
publication that reviewed subsequent patients that 
underwent robotic mitral repair at our institution with the 
da Vinci system (Kypson et al., 2003). The only time 
that did not change between the two groups was the 
annuloplasty band placement time. Most likely, this 
represents an inherent limitation in the current 
technology of tying suture knots. Even with extensive 
experience, the speed of suture placement is limited. 
Alternative methods of implanting the annuloplasty ring 
may decrease this time in the future. For the entire group 
of 38 patients, the mean length of stay was 3.8 days, with 
no difference between the two groups. For all patients in 
the study, 84% demonstrated a reduction of three or 
more grades in mitral regurgitation at follow-up. In the 
entire series there were no device-related complications 
or operative deaths. One valve was replaced at 19 days 
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because of hemolysis secondary to a leak that was 
directed against a prosthetic chord. 
Besides our own experience, results from a prospective 
multicenter phase II FDA trial were recently submitted 
(Chitwood Jr WR et al, in press.). In this trial involving 
10 institutions, the da Vinci system was used to perform 
mitral valve repairs in 112 patients. Valve repairs 
included quadrangular resections, sliding-plasties, edge-
to-edge approximations, and both chordal transfers and 
replacements. Leaflet repair times averaged 36.7 ± 0.2 
minutes with annuloplasty times of 39.6 ± 0.1 minutes. 
Total robotic, aortic cross-clamp, and cardiopulmonary 
bypass times were 77.9 ± 0.3 minutes, 2.1 ± 0.1 hours, 
and 2.8 ± 0.1 hours, respectively. At one-month follow-
up, transthoracic echocardiography revealed nine 
patients (8.0%) with greater than or equal to grade 2 
mitral regurgitation and six (5.4%) of these had re-
operations (five replacements, one repair). There were no 
deaths, strokes, or device-related complications. This 
study demonstrated that multiple surgical teams could 
perform robotic mitral valve surgery safely early in the 
development of this technique. 
 
7. Robotics in Coronary Artery Bypass Surgery 
 
In May 1998, Mohr and Falk harvested the left internal 
mammary artery (LIMA) with the da Vinci system and 
performed the first human coronary anastomosis through 
a small left anterior thoracotomy incision (Mohr et al., 
1999; Falk et al., 2000). More recently, work with da 
Vinci has lead to FDA approval for internal mammary 
harvesting in the United States. 
The first totally endoscopic coronary artery bypass 
(TECAB) was performed on an arrested heart at the 
Broussais Hospital in Paris using an early prototype of 
the da Vinci system (Loulmet et al., 1999). The Leipzig 
group attempted a total closed chest approach for LIMA 
to left anterior descending coronary artery (LAD) 
grafting on the arrested heart in 27 patients with da Vinci 
and was successful in 22 patients (Falk et al., 2000). 
Furthermore, surgeons in Europe improved the initial da 
Vinci coronary bypass graft method and eventually were 
able to complete off-pump bilateral grafts of the internal 
mammary artery to the anterior descending and right 
coronary arteries while working from one side of the 
chest (Aybek et al., 2000; Kappert et al., 2000). 
Experience with endoscopic coronary artery bypass 
surgery has been limited to only a few centers and results 
are highly controlled. Because the success of coronary 
surgery depends on multiple, complex steps culminating 
in the creation of a vascular anastomosis, most clinical 
series have introduced robotically assisted coronary 
surgery in a stepwise fashion. Specifically, initial 
experience is limited to endoscopic LIMA harvesting, 
followed by a robotically assisted anastomosis through a 
median sternotomy. Subsequently, a total endoscopic 
procedure is performed on an arrested heart, and finally 
during a beating heart operation. Currently, the largest 
published series of TECAB comes from Europe. 
Wimmer-Greinecker’s group in Frankfurt, Germany, 
reported on 45 patients who underwent TECAB on an 
arrested heart (Dogan et al., 2002). Most of these (82%) 
were single-vessel bypass (either LIMA-LAD or right 
internal mammary artery to right coronary artery). The 
first 22 patients had angiograms prior to discharge, 
revealing a 100% patency rate. Mean operative time was 
4.2 ± 0.9 hours for single-vessel TECAB and 6.3 ± 1.0 
hours for double-vessel bypass procedures. The average 
cross-clamp time was 61 ± 16 minutes for single bypass 
and 99 ± 55 minutes for double bypass. The initial 
conversion rate of 22% decreased to 5% in the last 
twenty patients, reflecting an obvious learning curve. 
In the United States, Damiano and his colleagues 
initiated a multicenter clinical trial on robotically assisted 
coronary surgery using the Zeus system (Damiano et al., 
2000). In this FDA safety and efficacy trial, 19 patients 
underwent a median sternotomy with cardioplegic arrest 
of the heart. All grafts were hand sewn in a traditional 
manner except the LIMA-LAD, which was robotically 
sewn. Seventeen patients had adequate intraoperative 
flow (mean 38.5 ± 5 mL/min) in the LIMA graft. 
Anastomotic time was 22.5 ± 1.2 minutes. One patient 
underwent re-exploration for mediastinal hemorrhage. At 
eight weeks follow-up, angiography showed that all 
grafts were patent. The average hospital stay was 4.1 ± 
0.4 days. Boyd and associates from London Health 
Sciences Center in Ontario, Canada, have also been 
extensively involved in initial endoscopic coronary 
surgery trials with the Zeus system. In 2000, they 
published a series of six patients that were the first to 
undergo TECAB in North America on a beating heart 
using a specialized endoscopic stabilizer (Boyd et al., 
2000). Each of these patients had single vessel LAD 
disease and underwent LIMA-LAD grafting. Special 8-0 
polytetrafluoroethylene suture 7 cm in length was used to 
minimize the time required for suture placement. 
Intracoronary shunts were used to provide needle depth 
landmark when performing endoscopic anastomosis with 
two-dimensional cameras. LIMA harvest time averaged 
65.3 ± 17.6 minutes (range 50-91 minutes). The 
anastomotic time was 55.8 ± 13.5 minutes (range 40-74 
minutes) and median operative time was 6 hours (range 
4.5-7.5 hours). All patients had angiographically 
confirmed patent grafts before leaving the hospital. The 
average hospital length of stay was 4.0 ± 0.9 days. 
 
8. Conclusion 
 
The early clinical experience with computer-enhanced 
telemanipulation systems has defined many of the 
limitations of this approach despite rapid procedural 
success. Currently, the lack of force feedback is being 
addressed and a strain sensor is being incorporated into 
advanced robotic surgical tools and may soon allow 
more control of force applied at the robotic end-effector 
(Zenati, 2001). Furthermore, conventional suture and 
knot tying add significant time to each procedure. 
Technologic advancements, such as the use of nitinol U-
clips (Coalescent Surgical Inc., Sunnyvale, CA) (Fig. 5) 
instead of sutures requiring manual knot tying, should  
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decrease operative times significantly. 
Besides advances in surgical technology, the potential 
use of image-guided surgical technologies will provide 
real-time data acquisition of physiologic characteristics, 
allowing one to better assess the delivery of remote 
percutaneous therapy. Imaging techniques may include 
three-dimensional modeling and reconstruction from 
computerized tomography, magnetic resonance imaging, 
or ultrasound. 
 
 
Fig. 5. Nitinol U-clips. 
 
Recently published research conducted at the National 
Research Institute in Computer Science and Control of 
France, in collaboration with Professor Carpentier, 
focuses on simulating and planning robotic procedures 
(Blondel et al., 2002). Computer modeling of organs 
such as the heart is generated from combined 
information from different imaging modalities. A 
surgeon may visualize and manipulate simulated objects 
interactively and once optimal access port placements are 
determined, the positions of the simulated tools can be 
recorded and marked directly on the patient to specify 
positions for port incisions. This technology should 
enable and facilitate totally endoscopic robotic cardiac 
operations and benefit the patient through decreased risks 
and fewer adverse operative outcomes. 
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